Amelioration of acute graft-versus-host disease by NKG2A engagement on donor T cells

European Journal of Immunology

Volumn 35, Issue 8, 2005, Pages 2358-2366

  Kawamura, Hiroki ^a,b   Yagita, Hideo ^b   Nisizawa, Tetsuro ^a   Izumi, Nakako ^a   Miyaji, Chikako ^a   Vance, Russell E ^c   Raulet, David H ^c   Okumura, Ko ^b   Abo, Toru ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute graft versus host disease; Cytotoxicity; NKG2A; T cell; Transplantation

Indexed keywords

ALLOANTIGEN; CD94 ANTIGEN; ISOPROTEIN; LYMPHOCYTE ANTIBODY; LYMPHOCYTE RECEPTOR;

ACUTE GRAFT VERSUS HOST DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE SUBPOPULATION;

ACUTE DISEASE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD94; CELL PROLIFERATION; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GRAFT VS HOST DISEASE; LECTINS, C-TYPE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 23844476925     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425933     Document Type: Article

References (40)

1. Tsukada, N., Kobata, T., Aizawa, Y., Yagita, H. and Okumura, K., Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation. Blood 1999. 93: 2738-2747.
2. Hattori, K., Hirano, T., Miyajima, H., Yamakawa, N., Tateno, M., Oshimi, K., Kayagaki, N. et al., Differential effects of anti-Fas ligand and anti-tumor necrosis factor α antibodies on acute graft-versus-host disease pathologies. Blood 1998. 91: 4051-4055.
3. Raulet, D. H., Vance, R. E. and McMahon, C. W., Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 2001. 19: 291-330.
4. Diefenbach, A. and Raulet, D. H., Strategies for target cell recognition by natural killer cells. Immunol. Rev. 2001. 181: 170-184.
5. Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R. and Moretta, L., Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 2001. 19: 197-223.
6. Lopez-Botet, M., Carretero, M., Bellon, T., Perez-Villar, J. J., Llano, M. and Navarro, F., The CD94/NKG2 C-type lectin receptor complex. Curr. Topics Microbiol. Immunol. 1998. 230: 41-52.
7. Braud, V. M. and McMichael, A. J., Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E. Curr. Topics Microbiol. Immunol. 1999. 244: 85-95.
8. b. J. Exp Med. 1998. 188: 1841-1848.
9. b by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. J. Exp. Med. 1999. 190: 1801-1812.
10. Braud, V. M., Allan, D. S. J., Wilson, D. and McMichael, A. J., TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 1998. 8: 1-10.
11. Bai, A., Broen, J. and Forman, J., The pathway for processing leader-derived peptides that regulate the maturation and expression of Qa-1b. Immunity 1998. 9: 413-421.
12. Lazetic, S., Chang, C., Houchins, J. P., Lanier, L. L. and Phillips, J. H., Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 1996. 157: 4741-4745.
13. Le, D. E., Vely, F., Olcese, L., Cambiaggi, A., Guia, S., Krystal, G., Gervois, N. et al., Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur. J. Immunol. 1998. 28: 264-276.
14. Lanier, L. L., Corliss, B., Wu, J. and Phillips, J. M., Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 1998. 8: 693-701.
15. Olcese, L., Cambiaggi, A., Semenzato, G., Bottino, C., Moretta, A. and Vivier, E., Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J. Immunol. 1997. 158: 5083-5086.
16. Lanier, L. L., Corliss, B. C., Wu, J., Leong, C. and Phillips, J. H., Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 1998. 391: 703-707.
17. + T cell responses. Nat. Immunol. 2002. 3: 189-195.
18. + T cells. Curr. Opin. Immunol. 2001. 13: 465-470.
19. b inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes. Int. Immunol. 2001. 13: 321-327.
20. + T cells in response to CD3-mediated stimulation. J. Leukoc. Biol. 2001. 70: 219-224.
21. Bertone, S., Schiavetti, F., Bellomo, R., Vitale, C., Ponte, M., Moretta, L. and Mingari, M. C., Transforming growth factor-β-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes. Eur. J. Immunol. 1999. 29: 23-29.
22. Galiani, M. D., Aguado, E., Tarazona, R., Romero, P., Molina, I., Santamaria, M., Solana, R. and Pena, J., Expression of killer inhibitory receptors on cytotoxic cells from HIV-1-infected individuals. Clin. Exp. Immunol. 1999. 115: 472-476.
23. Tanaka, J., Tutumi, Y., Li, Z., Katho, N., Sugita, J., Mori, A., Toyoshima, N. et al., Increased proportion of HLA-class-I-specific natural killer cell receptors (CD94) on peripheral blood mononuclear cells after allogeneic bone marrow transplantation. Acta Haematol. 2001. 105: 89-91.
24. + T cells. Proc. Natl. Acad. Sci. USA 1998. 95: 1172-1177.
25. + T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc. Natl. Acad. Sci. USA 1996. 93: 12433-12438.
26. + cells. J. Exp. Med. 2002. 195: 1523-1532.
27. + T cells. J. Exp. Med. 2002. 195: 1515-1522.
28. Speiser, D. E., Pittet, M. J., Valmori, D., Dunbar, R., Rimoldi, D., Lienard, D., MacDonald, H. R. et al., In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J. Exp. Med. 1999. 190: 775-782.
29. + T cells. J. Immunol. 2002. 169: 1444-1452.
30. + T cells. J. Immunol. 2002. 169: 693-701.
31. Jadus, M. R. and Wepsic, H. T., The role of cytokines in graft-versus-host reactions and disease. Bone Marrow Transplant. 1992. 10: 1-14.
32. Murphy, W. J. and Blazar, B. R., New strategies for preventing graft-versus-host disease. Curr. Opin. Immunol. 1999. 11: 509-515.
33. + T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-β. J. Immunol. 1999. 163: 3684-3691.
34. Shawar, S. M., Vyas, J. M., Rodgers, J. R. and Rich, R. R., Antigen presentation by major histocompatibility complex class I-B molecules. Annu. Rev. Immunol. 1994. 12: 839-880.
35. + cells of donor origin. Transplantation 1988. 45: 586-590.
36. Ellison, C. A., HayGlass, K. T., Fischer, J. M., Rector, E. S., MacDonald, G. C. and Gartner, J. G., Depletion of natural killer cells from the graft reduces interferon-gamma levels and lipopolysaccharide-induced tumor necrosis factor-alpha release in F1 hybrid mice with acute graft-versus-host disease. Transplantation 1998. 15: 284-294.
37. Ellison, C. A., Amadeo, R. J. and Gartner, J. G., GVHD-associated enteropathy and endotoxemia in F1-hybrid recipients of NK1.1-depleted grafts. Scand. J. Immunol. 2001. 54: 375-382.
38. Palmieri, G., Tullio, V., Zingoni, A., Piccoli, M., Frati, L., Lopez-Botet, M. and Santoni, A., CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells. J. Immunol. 1999. 162: 7181-7188.
39. Kawamura, H., Kawamura, T., Kokai, Y., Mori, M., Matsuura, A., Oya, H., Honda, S. et al., Expansion of extrathymic T cells as well as granulocytes in the liver and other organs of granulocyte-colony stimulating factor transgenic mice: why they lost the ability of hybrid resistance. J. Immunol. 1999. 162: 5957-5964.
40. + natural killer T cells in the liver with neonatal tolerance phenomenon. Transplantation 2002. 73: 978-984.